Cardiology, Zürcher RehaZentrum Wald, Switzerland; University Heart Center, Department of Cardiology, University Hospital Zurich, Switzerland.
AMIS Plus Data Center, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Int J Cardiol. 2018 Jun 15;261:1-5. doi: 10.1016/j.ijcard.2018.01.096.
Referral rates for cardiac rehabilitation (CR) after an acute myocardial infarction (AMI) are low despite a Class I recommendation in the present guidelines. Therefore, we aimed to identify predictors for referral and patient characteristics from the national Swiss AMIS Plus registry.
Data were extracted from the Swiss AMIS Plus registry between 2005 and 2017, which included patients with ST-elevation myocardial infarction (STEMI) and Non-ST-elevation myocardial infarction (NSTEMI). For 32,416 patient (93.2%) data about destination at discharge were available with 10,940 (33.7%) having a recommendation for CR while 12,282 (37.9%) went home. 9194 (28.4%) were transferred to another hospital after index hospitalisation and were excluded.
Patients referred to CR were younger (62.6 vs. 68.2 years) and had a higher prevalence of obesity (22.0% vs. 20.4%). Except for smoking (44.0% vs 34.9%), they had less risk factors such as dyslipidemia (55.0% vs. 60.1%), hypertension (55.6% vs. 65.3%) and diabetes (16.7% vs. 21.5%). Patients with in-hospital complications were more likely being referred for CR. Furthermore, STEMI (OR 1.61; CI 1.52-1.71), performed PCI (OR 2.65; CI 2.42-2.90) and Killip class >2 (OR 1.58; CI 1.36-1.84) favoured referral for CR, while age > 65 years, previous myocardial infarction, cerebrovascular disease or peripheral artery disease had a negative impact on referral for CR.
Our data from 23,222 patients after AMI demonstrate that in Switzerland patients referred for CR are younger, more obese with more STEMI. In-hospital complications were strong predictors for CR recommendation. Unlike anticipated, other risk factors were less present in CR patients.
尽管目前的指南将心脏康复(CR)推荐为 I 类,但急性心肌梗死(AMI)后的转诊率仍然很低。因此,我们旨在从瑞士 AMIS Plus 国家注册中心确定转诊和患者特征的预测因素。
2005 年至 2017 年期间,从瑞士 AMIS Plus 注册中心提取数据,其中包括 ST 段抬高型心肌梗死(STEMI)和非 ST 段抬高型心肌梗死(NSTEMI)患者。对于 32416 名患者(93.2%),出院时的目的地数据可用,其中 10940 名(33.7%)有 CR 推荐,而 12282 名(37.9%)回家。索引住院后,有 9194 名(28.4%)患者被转至另一家医院,被排除在外。
被转诊至 CR 的患者年龄较小(62.6 岁 vs. 68.2 岁),肥胖比例较高(22.0% vs. 20.4%)。除吸烟(44.0% vs. 34.9%)外,他们的其他危险因素如血脂异常(55.0% vs. 60.1%)、高血压(55.6% vs. 65.3%)和糖尿病(16.7% vs. 21.5%)的比例较低。发生院内并发症的患者更有可能被转诊至 CR。此外,STEMI(OR 1.61;95%CI 1.52-1.71)、行 PCI(OR 2.65;95%CI 2.42-2.90)和 Killip 分级>2(OR 1.58;95%CI 1.36-1.84)与 CR 推荐相关,而年龄>65 岁、既往心肌梗死、脑血管疾病或外周动脉疾病对 CR 推荐有负面影响。
我们对瑞士 23222 名 AMI 后患者的数据表明,在瑞士,被转诊至 CR 的患者更年轻、更肥胖,STEMI 比例更高。院内并发症是 CR 推荐的有力预测因素。与预期相反,CR 患者的其他危险因素较少。